Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026)

Hims & Hers Health (HIMS) reported Amortizatization of Intangibles of $242000.0 for Q1 2026, down 65.08% on a YoY basis from $693000.0 in Q1 2025, and down 66.34% sequentially from $719000.0 in Q4 2025.

Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of Amortizatization of Intangibles data on file, last reported at $242000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles fell 65.08% year-over-year to $242000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 60.19% YoY), and the FY2025 full-year result was $2.0 million, down 53.34% from the prior year.
  • Amortizatization of Intangibles fell to $242000.0 in Q1 2026, from $719000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q4 2023 to a low of -$971000.0 in Q1 2022.
  • A 5-year average of $715823.5 and a median of $840000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles plunged 238.33% in 2022 and jumped 1333.33% in 2023, its largest moves.
  • Tracing HIMS's Amortizatization of Intangibles over 5 years: stood at $840000.0 in 2022, then soared by 96.67% to $1.7 million in 2023, then slumped by 44.61% to $915000.0 in 2024, then dropped by 21.42% to $719000.0 in 2025, then plunged by 66.34% to $242000.0 in 2026.
  • Business Quant data shows HIMS's Amortizatization of Intangibles at $242000.0 in Q1 2026, $719000.0 in Q4 2025, and $253000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 242,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 242,000.00
Mar 31, 2026 242,000.00
Dec 31, 2025 719,000.00
Dec 31, 2025 719,000.00
Sep 30, 2025 253,000.00
Sep 30, 2025 253,000.00
Jun 30, 2025 367,000.00
Jun 30, 2025 367,000.00
Mar 31, 2025 693,000.00
Mar 31, 2025 693,000.00
Dec 31, 2024 915,000.00
Dec 31, 2024 915,000.00
Sep 30, 2024 1.16 Mn
Sep 30, 2024 1.16 Mn
Jun 30, 2024 1.20 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.08 Mn
Mar 31, 2024 1.08 Mn
Dec 31, 2023 1.65 Mn
Dec 31, 2023 1.65 Mn